open access
메뉴ISSN : 0376-4672
To overcome shortcoming of autogeneous, allogenic, xenogenic and alloplastic bone grafts, various growth factors related to bone regeneration have been identified and developed. Among them, rhBMP-2 is regarded as the most potent osteoinductive growth factor and it can trigger the differentiation of mesenchymal stem cells to osteogenic cells for accelerated new bone formation And several commercial products of rhBMP-2 are available in Korea. It is applied to maxillary sinus augmentation, guided bone regeneration and preservation of extraction socket. In this review, the development, action mechanism and clinical applications of rhBMP-2 will be described.
1. Chiapasco M, Di Martino G, Anello T, Zaniboni M, Romeo E: Fresh Frozen versus Autogenous Iliac Bone for the Rehabilitation of the Extremely Atrophic Maxilla with Onlay Grafts and Endosseous Implants: Preliminary Results of a Prospective Comparative Study. Clin Implant Dent Relat Res, 2013
2. Martuscelli R, Toti P, Sbordone L, Guidetti F, Ramaglia L, Sbordone C: Five-year outcome of bone remodelling around implants in the maxillary sinus: assessment of differences between implants placed in autogenous inlay bone blocks and in ungrafted maxilla. Int J Oral Maxillofac Surg, 2014
3. von Arx T, Cochran DL, Hermann JS, Schenk RK, Buser D: Lateral ridge augmentation using different bone fillers and barrier membrane application. A histologic and histomorphometric pilot study in the canine mandible. Clin Oral Implants Res 2001; 12: 260-269
4. de Lange GL, Overman JR, Farre-Guasch E, Korstjens CM, Hartman B, Langenbach GE, et al:A histomorphometric and micro-computed tomography study of bone regeneration in the maxillary sinus comparing biphasic calcium phosphate and deproteinized cancellous bovine bone in a human split-mouth model. Oral Surg Oral Med Oral Pathol Oral Radiol 2014; 117: 8-22
5. Bignon A, Chouteau J, Chevalier J, Fantozzi G, Carret JP, Chavassieux P, Boivin G, Melin M, Hartmann D. Effect of micro- and macroporosity of bone substitutes on their mechanical properties and cellular response. Journal of Materials Science:Materials in Medicine 2003; 14: 1089-1097
6. Triplett RG, Nevins M, Marx RE, Spagnoli DB, Oates TW, Moy PK, et al: Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation. J Oral Maxillofac Surg 2009; 67: 1947-1960
7. Gutwald R, Haberstroh J, Stricker A, Ruther E, Otto F, Xavier SP, et al: Influence of rhBMP-2 on bone formation and osseointegration in different implant systems after sinus-floor elevation. An in vivo study on sheep. J Craniomaxillofac Surg 2010; 38: 571-579
8. Carragee EJ, Hurwitz EL, Weiner BK: A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 2011; 11: 471-491
9. Urist MR: Bone: formation by autoinduction. Science 1965; 150:893-899
10. Carreira AC, Lojudice FH, Halcsik E, Navarro RD, Sogayar MC, Granjeiro JM: Bone morphogenetic proteins: facts, challenges, and future perspectives. J Dent Res 2014; 93: 335-345
11. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, et al: Novel regulators of bone formation: molecular clones and activities. Science 1988; 242: 1528-1534,
Bessho K, Konishi Y, Kaihara S, Fujimura K, Okubo Y, Iizuka T: Bone induction by Escherichia coli -derived recombinant human bone morphogenetic protein-2 compared with Chinese hamster ovary cell-derived recombinant human bone morphogenetic protein-2. Br J Oral Maxillofac Surg 2000; 38: 645-649
13. Yano K, Hoshino M, Ohta Y, Manaka T, Naka Y, Imai Y, et al: Osteoinductive capacity and heat stability of recombinant human bone morphogenetic protein-2 produced by Escherichia coli and dimerized by biochemical processing. J Bone Miner Metab 2000; 27: 355-363,
14. Kim IS, Lee EN, Cho TH, Song YM, Hwang SJ, Oh JH, et al: Promising efficacy of Escherichia coli recombinant human bone morphogenetic protein-2in collagen sponge for ectopic and orthotopic bone formation and comparison with mammalian cell recombinant human bone morphogenetic protein-2. Tissue Eng Part A 2011; 17: 337-348,
15. Kim RY, Oh JH, Lee BS, Seo YK, Hwang SJ, Kim IS. The effect of dose on rhBMP-2 signaling, delivered via collagen sponge, on osteoclast activation and in vivo bone resorption. Biomaterilas 2014; 35: 1869-1881,
15. Jung RE, Glauser R, Scharer P, Hammerle CH, Sailer HF, Weber FE: Effect of rhBMP-2 on guided bone regeneration in humans. Clin Oral Implants Res 2003; 14: 556-568,